Gland Pharma informs about press release

15 Nov 2023 Evaluate
Gland Pharma has informed that it enclosed attached press release on ‘Gland Pharma receives tentative approval from the United States Food and Drug Administration (US FDA) for Angiotensin II for Injection, 2.5 mg/ ml Single-Dose Vial’

The above information is a part of company’s filings submitted to BSE.


Gland Pharma Share Price

1651.60 -1.75 (-0.11%)
29-Dec-2025 14:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1712.10
Dr. Reddys Lab 1267.35
Cipla 1494.60
Zydus Lifesciences 905.05
Lupin 2085.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×